Classification of dopamine antagonists using functional feature hypothesis and topological descriptors.
暂无分享,去创建一个
Yong Seo Cho | Ae Nim Pae | Kyoung Tai No | Hun Yeong Koh | Jae Yang Kong | Y. Cho | H. Koh | A. Pae | K. No | Hyeno Kim | Hye-Jung Kim | J. Kong
[1] Bruno Giros,et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.
[2] Andrew Smellie,et al. Poling: Promoting conformational variation , 1995, J. Comput. Chem..
[3] H. Hall,et al. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions , 2004, Psychopharmacology.
[4] P. Seeman,et al. Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.
[5] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[6] J. Hagan,et al. Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. , 2000, Journal of medicinal chemistry.
[7] L. Hall,et al. Molecular connectivity in chemistry and drug research , 1976 .
[8] Kurt Hornik,et al. Multilayer feedforward networks are universal approximators , 1989, Neural Networks.
[9] Svante Wold,et al. Pattern recognition by means of disjoint principal components models , 1976, Pattern Recognit..
[10] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[11] Gerhard Klebe,et al. A 3D QSAR Study on a Set of Dopamine D4 Receptor Antagonists , 2003, J. Chem. Inf. Comput. Sci..
[12] M. Millan,et al. S18327 (1-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors: II. Functional Profile and a Multiparametric Comparison with Haloperidol, Clozapine, and 11 Othe , 2000 .
[13] Jonas Boström,et al. A pharmacophore model for dopamine D4 receptor antagonists , 2000, J. Comput. Aided Mol. Des..
[14] M. Millan,et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. , 1998, The Journal of pharmacology and experimental therapeutics.
[15] Bruno Giros,et al. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.
[16] K. M. Smith,et al. Novel software tools for chemical diversity , 1998 .
[17] J. Hagan,et al. Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists. , 1996, Journal of medicinal chemistry.
[18] M. Millan,et al. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist. , 1999, Bioorganic & medicinal chemistry letters.
[19] Lowell H. Hall. Computational aspects of molecular connectivity and its role in structure-property modeling , 1990 .
[20] M. Millan,et al. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. , 2000, The Journal of pharmacology and experimental therapeutics.
[21] Jonathan S. Mason,et al. Chemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection , 1998, J. Chem. Inf. Comput. Sci..
[22] P. Seeman. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[23] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[24] P. Strange,et al. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. , 2001, Pharmacological reviews.
[25] S. Unger. Molecular Connectivity in Structure–activity Analysis , 1987 .
[26] D. Evans,et al. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. , 1993, European journal of pharmacology.
[27] Yoshimasa Takahashi,et al. Classification of Dopamine Antagonists Using TFS-Based Artificial Neural Network , 2004, J. Chem. Inf. Model..
[28] J. Hagan,et al. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist. , 2003, Journal of medicinal chemistry.
[29] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .